These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 6152561)

  • 1. Arylsulfatase A activities in urine and tissues taken from bladder cancer patients.
    Mitsuhashi K; Maru A; Koyanagi T; Ishibashi T; Imai Y; Gasa S; Taniguchi N; Makita A
    Jpn J Exp Med; 1984 Oct; 54(5):211-6. PubMed ID: 6152561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arylsulfatase A activity of urine in patients with various genitourinary tract disorders.
    Maru A; Ishibashi T; Imai Y; Makita A; Tsuji I
    Clin Chim Acta; 1980 Nov; 107(3):155-61. PubMed ID: 6108168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of a variant form of urinary arylsulfatase A.
    Kosugi M; Maru A; Mitsuhashi K; Koyanagi T; Ishibashi T; Imai Y
    Jpn J Exp Med; 1983 Apr; 53(2):73-6. PubMed ID: 6141312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary glucuronidase and arylsulfatases in identical twins of bladder cancer patients.
    Paigen B; Yarfitz S; Tabron D
    Cancer Res; 1984 Aug; 44(8):3624-6. PubMed ID: 6146401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The heterogeneity of arylsulphatase-A and arylsulphatase-B in normal human urine and urine from cancer patients.
    Dowden G; Davey R
    Biochem Int; 1987 Oct; 15(4):843-51. PubMed ID: 2893617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of diagnostic and prognostic values of urinary interleukin-8, tumor necrosis factor-alpha, and leukocyte arylsulfatase-A activity in patients with bladder cancer.
    Koçak H; Oner-Iyidoğan Y; Koçak T; Oner P
    Clin Biochem; 2004 Aug; 37(8):673-8. PubMed ID: 15302609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Arylsulfate sulfohydroxylase A (E.C.3.1.6.1.) in bladder urothelial tumors and the semiologic value of other lysosomal hydroxylases].
    Mayor JJ; Arenas J; Fraile B; Santos I; Leiva O; Sanz R; Díaz R; Martínez A; Borobia V
    Actas Urol Esp; 1984; 8(1):11-20. PubMed ID: 6144249
    [No Abstract]   [Full Text] [Related]  

  • 8. Urinary and tissue levels of scatter factor in transitional cell carcinoma of bladder.
    Rosen EM; Joseph A; Jin L; Yao Y; Chau MH; Fuchs A; Gomella L; Hastings H; Goldberg ID; Weiss GH
    J Urol; 1997 Jan; 157(1):72-8. PubMed ID: 8976219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urine enzyme activities in patients with transitional cell carcinoma of the bladder.
    Posey LE; Morgan LR
    Clin Chim Acta; 1977 Jan; 74(1):7-10. PubMed ID: 12890
    [No Abstract]   [Full Text] [Related]  

  • 10. Expression of cyclooxygenase-2 in patients with bladder carcinoma.
    Yoshimura R; Sano H; Mitsuhashi M; Kohno M; Chargui J; Wada S
    J Urol; 2001 May; 165(5):1468-72. PubMed ID: 11342898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Studies on arylsulfatase A of bladder cancer].
    Mitsuhashi K
    Nihon Hinyokika Gakkai Zasshi; 1984 Sep; 75(9):1372-9. PubMed ID: 6151607
    [No Abstract]   [Full Text] [Related]  

  • 12. [Expression of cyclooxygenase-2 in human transitional cell bladder carcinomas].
    Zhan J; Tang XD
    Ai Zheng; 2002 Nov; 21(11):1212-6. PubMed ID: 12526218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of telomerase activity in bladder carcinoma and exfoliated cells collected in urine and bladder washings, using a quantitative assay.
    Gelmini S; Crisci A; Salvadori B; Pazzagli M; Selli C; Orlando C
    Clin Cancer Res; 2000 Jul; 6(7):2771-6. PubMed ID: 10914723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arylsulfatases in bilharziasis.
    Khafagy EZ; Raziky HE; Galal AF
    Egypt J Bilharz; 1976; 3(2):213-9. PubMed ID: 23942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary arylsulfatase in normal children and in patients with pediatric malignant disease.
    Ueno N; Matsumoto T; Ohkawa M; Nakayama M; Tono-oka T
    Tohoku J Exp Med; 1983 Feb; 139(2):165-9. PubMed ID: 6132469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Urinary excretion of arylsulfatases A and B in patients with renal transplants].
    Cavallini M; Palestini M; Antonucci A; Proia G; Tersigni R
    Minerva Chir; 1980 May; 35(10):727-30. PubMed ID: 6109266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-derived hyaluronidase: a diagnostic urine marker for high-grade bladder cancer.
    Pham HT; Block NL; Lokeshwar VB
    Cancer Res; 1997 Feb; 57(4):778-83. PubMed ID: 9044860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Urinary enzyme determination and its clinical significance. B. Enzymes derived from the urogenital system. 3. Arylsulfatase A].
    Miyatani N; Miyatake T
    Rinsho Byori; 1983 Sep; Spec No 56():32-6. PubMed ID: 6141306
    [No Abstract]   [Full Text] [Related]  

  • 19. Prognostic significance of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 in voided urine samples from patients with transitional cell carcinoma of the bladder.
    Durkan GC; Nutt JE; Rajjayabun PH; Neal DE; Lunec J; Mellon JK
    Clin Cancer Res; 2001 Nov; 7(11):3450-6. PubMed ID: 11705862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radioimmunoassay for arylsulfatase A in urine.
    Laidler PM; Ryder KW; Glick MR; Oei TO; Van Etten RL
    Clin Chem; 1985 Mar; 31(3):391-6. PubMed ID: 2857600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.